IVERIC bio, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2023.

Location
Parsippany, NJ
Fiscal year end
31 December
Latest financial report
10 May 2023

Quick Takeaways

  • IVERIC bio, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q1 2023.
  • Headline metric: Return On Equity -55%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+13%</span>.
  • Most recent SEC facts end date: 01 May 2023.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2023-05-01) highlights Return On Equity -55.0%, Return On Assets -46.1%, and Current Ratio 15.53x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

20.3/100

Weak Confidence medium

Return On Equity

-55%

Metric score 0.0/100

Return On Assets

-46%

Metric score 0.0/100

Financial Health

Current Ratio
15.53x
Debt to Equity
0.24x

Strengths

Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Current Ratio

Key metrics snapshot

Return On Equity

-55%

YoY: +13%

Industry median: -43% (n=675)

View history

Return On Assets

-46%

YoY: +1.9%

Industry median: -47% (n=673)

View history

Current Ratio

15.53x

YoY: -15%

Industry median: 3.39x (n=667)

View history

Debt-to-equity

0.24x

YoY: +160%

Industry median: 0.26x (n=530)

View history

NetIncomeLoss YoY

-82%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -55% +13%
Return On Assets -46% +1.9%

Financial Health

Metric Latest value YoY change
Current Ratio 15.53x -15%
Debt-to-equity 0.24x +160%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -82%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 137,782,748 +18%
Common Stock, Shares, Outstanding 137,249,579 +18%
Common Stock, Value, Issued $137,000 +18%
Weighted Average Number of Shares Outstanding, Basic 137,087,000 +15%
Weighted Average Number of Shares Outstanding, Diluted 137,087,000 +15%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $136,538,000 +53%
General and Administrative Expense $92,539,000 +176%
Operating Income (Loss) $229,077,000 -87%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $222,904,000 -82%
Income Tax Expense (Benefit) $0
Earnings Per Share, Basic -2 -58%
Earnings Per Share, Diluted -2 -58%
Cash and Cash Equivalents, at Carrying Value $467,572,000 +144%
Assets, Current $611,543,000 +74%
Property, Plant and Equipment, Net $1,109,000 +150%
Operating Lease, Right-of-Use Asset $755,000 -42%
Other Assets, Noncurrent $0
Assets $613,407,000 +74%
Liabilities, Current $39,374,000 +105%
Operating Lease, Liability, Noncurrent $0 -100%
Liabilities $136,361,000 +597%
Accumulated Other Comprehensive Income (Loss), Net of Tax $99,000 +75%
Retained Earnings (Accumulated Deficit) $937,035,000 -31%
Stockholders' Equity Attributable to Parent $477,046,000 +43%
Liabilities and Equity $613,407,000 +74%
Share-based Payment Arrangement, Noncash Expense $11,899,000 +121%
Net Cash Provided by (Used in) Operating Activities $50,593,000 -35%
Net Cash Provided by (Used in) Financing Activities $2,589,000 +24%
Net Cash Provided by (Used in) Investing Activities $39,272,000
Common Stock, Shares Authorized 200,000,000 0%
Common Stock, Shares, Issued 137,249,579 +18%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,732,000 +87%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $467,572,000 +144%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,406,000
Operating Lease, Liability $774,000
Depreciation $70,000 +233%
Payments to Acquire Property, Plant, and Equipment $233,000 +101%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $222,609,000 -81%
Lessee, Operating Lease, Liability, to be Paid $786,000
Operating Lease, Liability, Current $774,000 -19%
Lessee, Operating Lease, Liability, to be Paid, Year One $11,000
Operating Lease, Weighted Average Discount Rate, Percent 0.06
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $12,000
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 5,000,000 0%
Operating Lease, Payments $1,500,000 +33%
Additional Paid in Capital $1,414,043,000 +35%
Preferred Stock, Shares Outstanding 0
Share-based Payment Arrangement, Expense $33,189,000 +131%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY